AmplifyMD

Profile (continued)

Leadership expanded significantly through 2025-2026: Nijay Patel serves as CTO (previously in a product role at health-data interoperability company Redox). Kurt Blasena joined as Chief Commercial Officer in April 2026, bringing over 20 years of health-tech go-to-market experience, most recently as Chief Commercial Officer at Digital Diagnostics and before that as Chief Revenue Officer at Viz.ai (2020-2024) during its rapid growth phase; he holds a degree from University of Wisconsin-Eau Claire. In January 2026, AmplifyMD announced governance additions: Dr. Stephen K. Klasko (former President & CEO of Thomas Jefferson University and Jefferson Health, now Executive in Residence at General Catalyst) joined the Board of Directors, and Dr. Rod Hochman (CEO Emeritus of Providence health system and former Chair of the American Hospital Association) joined as a Strategic Advisor (not board).

Commercially, AmplifyMD has grown from ~150 acute care telemedicine programs (mid-2024) to 300+ programs (September 2025) to 400+ clinical programs nationwide (April 2026), covering 15+ medical specialties and reportedly supporting tens of thousands of virtual encounters monthly. A notable partnership was announced July 29, 2024 with Sound Physicians, a large multispecialty medical group (400+ hospitals, 4,000+ clinicians across 45+ states), which selected AmplifyMD to power its TeleHospitalist programs. Memorial Hermann Health System is both a strategic investor (Series B) and an implied platform customer/partner. The company has also received significant industry recognition: SOC 2 Type 2 compliance (March 2023), Fast Company 'Next Big Things in Tech' 2023 winner, MedTech Breakthrough 'Virtual Care Innovation Award' (2024) and 'Best Overall Telemedicine Platform' in both 2025 and 2026 (10th annual awards, second consecutive year), Digital Health Hub 'Rising Star' Health Equity award (October 2024), a KLAS Research A+ rating across all categories in its Emerging Company Spotlight report (April 2025), and recognition as a KLAS 2025 Top 20 Emerging Solution — the only company to be a leading emerging solution in three of four KLAS Quadruple Aim categories (October 2025).

On competitive positioning, Crunchbase lists Caregility, TytoCare, and eVisit as comparable/competitor telemedicine platforms; the broader competitive set for hospital-based specialist telehealth access also plausibly includes companies like Access TeleCare and SOC Telemed (now part of Access TeleCare), though these were not independently confirmed via a cited source for this profile and are therefore omitted from the structured competitors list. AmplifyMD's core differentiation, per company and investor messaging, is deep EHR integration plus AI-driven workflow orchestration (case activation, specialist assignment, documentation, and billing) layered on top of either a client's own physician staff or AmplifyMD's specialist network — positioned as a 'clinical operating system' for hospital specialty care rather than a point-solution video visit tool.

Go-to-market

Hospitals and health systems (particularly rural and community hospitals lacking on-site specialty coverage), multispecialty medical groups (e.g., Sound Physicians) that deliver hospitalist/specialist services on behalf of hospitals, and large health system strategic partners (e.g., Memorial Hermann Health System).

Ownership

private